Rapidly Disintegrating Tablets via Fine-Grained Disintegrants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing rapidly disintegrating tablets lack mechanical strength, often produce an unpleasant sandy mouthfeel, and fail to disintegrate quickly enough, while also being difficult to produce efficiently.

Innovation Solution

Formulations comprising 60-97% sugar or sugar alcohols, 1-25% disintegrants like croscarmellose, 1-15% water-insoluble film-forming polymers, and optional water-soluble polymers and excipients, produced through agglomeration processes such as fluidized bed or spray drying, which enhance disintegration time and mechanical stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If spray-dried mannitol and cross-linked PVP are used to create rapidly disintegrating tablets, then disintegration time is reduced to within 60 seconds, but mechanical strength decreases to approx. 40N and sandy mouthfeel is produced

Engineering Contradiction:
Improvedisintegration timeVSAvoidmechanical strength
Core Design Contradiction:
Loss of timeVSStrength

Solution Approach 1:

The patent changes the particle size parameter of the disintegrant from coarse-grained to fine-grained (average particle size 10-50 μm), which fundamentally alters the tablet properties. This parameter change enables achieving both rapid disintegration (within 30 seconds) and high mechanical strength (>50N breaking strength), resolving the contradiction between speed and strength that existed with coarse-grained disintegrants

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite formulation combining fine-grained disintegrant (1-25% by weight), water-insoluble polymer (1-15% by weight), and sugar/sugar alcohol (60-97% by weight). This composite structure allows the fine-grained disintegrant to provide rapid disintegration while the water-insoluble polymer matrix maintains mechanical integrity, achieving both quick disintegration and high strength simultaneously

Inventive Principle:
Principle #40Composite materials

2Loss of time

If high proportion of coarse-grained disintegrant is used, then disintegration is enhanced, but mechanical strength decreases and sandy mouthfeel is produced

Engineering Contradiction:
Improvedisintegration timeVSAvoidsandy mouthfeel
Core Design Contradiction:
Loss of timeVSObject-generated harmful factors

Solution Approach 1:

The patent fundamentally changes the particle size parameter of the disintegrant from coarse-grained to fine-grained (average particle size 10-50 μm). This parameter change eliminates the sandy mouthfeel caused by coarse particles while maintaining rapid disintegration capability, as the fine particles can still effectively promote disintegration without providing a gritty sensation in the mouth

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If direct tabletting is used, then production ease is improved, but mechanical strength may be insufficient to withstand packaging and transport

Engineering Contradiction:
Improveproduction easeVSAvoidmechanical strength
Core Design Contradiction:
Ease of manufactureVSStrength

Solution Approach 1:

The patent develops a composite formulation specifically optimized for direct tabletting: fine-grained disintegrant (1-25% by weight), water-insoluble polymer (1-15% by weight), and sugar/sugar alcohol (60-97% by weight). This composite structure provides sufficient mechanical strength (>50N breaking strength) to withstand packaging and transport while maintaining the simplicity of direct tabletting production

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent optimizes the particle size parameter of the disintegrant to fine-grained (10-50 μm) and adjusts the formulation ratios to achieve the right balance between compressibility and mechanical strength. This allows direct tabletting to produce tablets with sufficient strength for commercial distribution while keeping the manufacturing process simple and efficient

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The tablets disintegrate within 20-40 seconds, have high mechanical strength (>50N breaking strength), and a pleasant mouthfeel, with improved reproducibility and ease of production.

Implementation Method 1

water-insoluble film-forming polymers

Methodology Applied
Scientific EffectFilm formation:

Implementation Method 2

the tablets disintegrate within 20-40 seconds

Methodology Applied
Scientific EffectDisintegration:

Implementation Method 3

disintegrants like croscarmellose, cross-linked sodium carboxymethyl starch, and L-hydroxypropyl cellulose

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Implementation Method 4

disintegrating agent selected from the group consisting of croscarmellose, cross-linked sodium carboxymethyl starch and L-hydroxypropyl cellulose

Methodology Applied
Scientific EffectSwelling:

Implementation Method 5

produced through agglomeration processes such as fluidized bed or spray drying

Methodology Applied
Scientific EffectAgglomeration:

Implementation Method 6

spray drying

Methodology Applied
Scientific EffectSpray drying:

Implementation Method 7

fluidized bed

Methodology Applied
Scientific EffectFluidization: Fluidisation

Data Source

PatentEP2170273B1Pharmaceutical formulation for the production of rapidly disintegrating tablets
Publication Date: 2014.11.26 BASF SE

AI summary

The invention relates to a pharmaceutical formulation in the form of compacts containing a) 60 - 97 % by weight of sugar or sugar alcohols, b) 1 - 25 % by weight of a disintegration agent selected from the group consisting of croscarmellose, sodium carboxymethyl starch and L-hydroxypropyl cellulose, c) 1 - 15 % by weight of water insoluble film-forming polymers, d) 0 - 15 % by weight of water-soluble polymers, and e) 0 - 15 % by weight of additional conventional pharmaceutical adjuvants, the sum of the components a) to e) totalling 100 % by weight.